无泵驱动体外膜肺转流治疗急性呼吸衰竭犬过程中血浆与肺组织ET.docVIP

无泵驱动体外膜肺转流治疗急性呼吸衰竭犬过程中血浆与肺组织ET.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
无泵驱动体外膜肺转流治疗急性呼吸衰竭犬过程中血浆和肺组织ET   作者:闫炀,耿希刚  作者单位:西安交通大学医学院第一附属医院心脏外科,陕西西安   【关键词】 急性呼吸衰竭;,内皮素   摘要:目的 观察双侧股动脉股静脉无泵驱动体外膜肺(bAVECMO)治疗急性呼吸衰竭(ARF)犬过程中血浆和肺组织肿瘤坏死因子Α(TNFΑ)和内皮素1(ET1)的变化。方法 10只犬在建立ARF模型情况下给予bAVECMO治疗。分别于实验各时段提取肺组织及血浆,应用放射免疫技术检测TNFΑ、ET1的变化。结果 模型动物血浆ET1含量先降低,1h后开始回升,2h达到高值;肺组织匀浆ET1含量增加在转流2h达到高值。方差分析表明匀浆和血浆各自ET1的均数在转流前后有显著性差异(P0.05)。肺组织匀浆和血浆TNFΑ含量转流3h后均较术前有所增高,但都呈现出先降低后升高的趋势。方差分析表明匀浆和血浆中各自TNFΑ的均数在转流前后有显著性差异(P0.05)。结论 bAVECMO早期转流可能减少ET1的释放;而TNFΑ在转流早期对于ET1释放影响不大。   关键词:急性呼吸衰竭; 内皮素1;肿瘤坏死因子Α; 无泵驱动体外膜肺   Changes of ET1 and TNFΑ in dog ARF model during bilateral femoral arteriovenous shunt for extracorporeal membrane oxygenation   Yan Yang, Geng Xigang   (Department of Cardiac Surgery, the First Affiliated Hospital, Medical School of Xian Jiaotong University, Xian 710061, China)   ABSTRACT: Objective To study the changes of endothelin1(ET1) and tumor necrosis factor alpha(TNFΑ) in lung homogenate and plasm when acute respiratory failure (ARF) animal models are treated by bilateral femoral arteriovenous extracorporeal membrane oxygenation(bAVECMO). Methods Ten ARF dog models were treated by the bAVECMO. Right atrium blood and lung tissues were collected at different time points, and ET1 and TNFΑ were assayed by radioimmunological method. Results ET1 content in plasm decreased at first, and at 1h it was elevated and at 2h reached the peak. ET1 content in lung homogenate reached the peak at 2h and then started to decrease. The analysis of variance showed notable differences(P0.05). TNFΑ content in lung homogenate and plasm decreased at 1h and started to increase after that time; it was higher at 3h than that at the beginning of operation and increased continuously. The analysis of variance showed notable differences (P0.05). Conclusion Early bAVECMO can possibly reduce the release of ET1, while TNFΑ has no obvious effect on ET1 release during bAVECMO.   KEY WORDS: acute respiratory failure(ARF); endothelin1(ET1); tumor necrosis factor al

文档评论(0)

youyang99 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档